This Site and Investigator Spotlight introduces Tariro Makadzange, MD, PhD, from the Charles River Medical Group, Pvt, Ltd (CRMG), in Harare, Zimbabwe. CMRG is listed in FHI Clinical’s database of research sites, and we look forward to working with Dr. Makadzange’s team in the future on research projects that align with their capabilities and the local epidemiology and healthcare needs.

Dr. Makadzange and CMRG were spotlighted in January 2023, and all information on this page is current as of then.

About Dr. Makadzange

Tariro Makadzange founded CRMG and Mutala Research in late 2021, to help address the need for expertise in pandemic responsiveness and clinical trials in Africa, following more than 15 years of experience in clinical, academic and pharma roles. Her research has focused primarily on HIV immunology and implementation science as well as related opportunistic infections such as cryptococcal meningitis, in both perinatally HIV-infected children/adolescents and HIV-infected adults. She has trained and mentored clinicians and researchers in HIV and co-established the Parirenyatwa Hospital Family Care Centre (PHFCC) at the University of Zimbabwe College of Health Sciences (UZCHS), which is now one of the largest HIV treatment programs in Zimbabwe. In the pharmaceutical industry, she led a therapeutic vaccine research program at Gilead Sciences.

She earned an MD at Harvard Medical School and a PhD (DPhil) in Immunology at the University of Oxford University. She trained in Internal Medicine at the University of Washington and completed a fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital, where she later joined the faculty and formed a research partnership that resulted in the establishment of the Infectious Diseases Research Laboratory in Harare. She has also held academic positions at Harvard Medical School, Stanford University and the University of Zimbabwe.

She is a member of the Vaccine Safety and Confidence-Building Working Group at Columbia University and a board member of PSI (Population Services International). She is committed to capacity building for research in Africa and hopes to inspire young Africans to take the lead in finding scientific solutions to medical problems prevalent in Africa.
Publications over the last ten years include:

more site spotlights

Focus on Sites

Lucas Tina, MD, MPH; VIBRI and KEMRI


Dr. Lucas Tina is affiliated with the Victoria Biomedical Research Institute (VIBRI) and Kenya Medical Research Institute (KEMRI) in Kisumu, Kenya. Dr. Tina serves as a Scientific Advisory Expert for FHI Clinical, and VIBRI and KEMRI are listed in FHI Clinical’s database of research sites.
Focus on Sites

Tariro Makadzange, MD, PhD; Charles River Medical Group, Pvt, Ltd (CRMG)


Tariro Makadzange, MD, PhD, is the Executive Director and Founder of Charles River Medical Group, Pvt, Ltd (CRMG), in Harare, Zimbabwe. CMRG is listed in FHI Clinical’s database of research sites.
Focus on Sites

Nsengi Ntamabyaliro, MD, MSc; UPC-PV, University of Kinshasa

Democratic Republic of the Congo (DRC)

FHI Clinical has worked with Nsengi Ntamabyaliro, MD, MSc, from the Unit of Clinical Pharmacology and Pharmacovigilance (UPC-PV), University of Kinshasa, in Kinshasa, Democratic Republic of the Congo (DRC), on Phase 3 and 4 trials since 2007, at which time there was a focus on research capacity development in the DRC.